| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| K Y Ho, G A Smythe, L Lazaru. Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia. Clinical endocrinology. vol 20. issue 1. 1984-03-21. PMID:6420095. |
we therefore investigated the importance of dopaminergic control of gonadotrophin secretion by studying lh, fsh and prl responses in normal and php subjects to central dopamine synthesis inhibition using monoiodotyrosine (mit) and to a 4 h dopamine infusion designed to elevate peripheral plasma dopamine concentration to levels reported for pituitary portal plasma (1-6 ng/ml). |
1984-03-21 |
2023-08-12 |
human |
| K Y Ho, G A Smythe, L Lazaru. Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia. Clinical endocrinology. vol 20. issue 1. 1984-03-21. PMID:6420095. |
we conclude that the inhibitory action of dopamine on prl release restores lh secretion by removing central dopaminergic inhibition through hypothalamic feedback of prl. |
1984-03-21 |
2023-08-12 |
human |
| C C Ouimet, P E Miller, H C Hemmings, S I Walaas, P Greengar. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 4. issue 1. 1984-03-15. PMID:6319625. |
moreover, the staining pattern supports the conclusion that the darpp-32 is present in dopaminoceptive neurons, i.e., neurons that receive a dopamine input, and that it is absent from the dopaminergic neurons themselves. |
1984-03-15 |
2023-08-12 |
Not clear |
| A Orti. Neuropharmacological profile of Meige's disease: overview and a case report. Clinical neuropharmacology. vol 6. issue 4. 1984-03-14. PMID:6661728. |
a patient with meige's disease was given several pharmacological trials, including muscle relaxants, dopaminergic antagonists, monoamine depletors, anticholinergics, dopamine agonists, cholinergics, benzodiazepines, tricyclic antidepressants, and lithium. |
1984-03-14 |
2023-08-12 |
Not clear |
| L F Agnati, K Fuxe, L Calza, F Benfenati, L Cavicchioli, G Toffano, M Goldstei. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. Acta physiologica Scandinavica. vol 119. issue 4. 1984-03-12. PMID:6141701. |
gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. |
1984-03-12 |
2023-08-12 |
rat |
| M Williams, G E Martin, D E McClure, J J Baldwin, K J Watlin. Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina. Naunyn-Schmiedeberg's archives of pharmacology. vol 324. issue 4. 1984-03-08. PMID:6141532. |
interaction of the component enantiomers of the putative dopamine autoreceptor agonist, tl-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina. |
1984-03-08 |
2023-08-12 |
mouse |
| R Romo, A Chéramy, M Desban, G Godeheu, J Glowinsk. GABA in the intralaminar thalamic nuclei modulates dopamine release from the two dopaminergic nigro-striatal pathways in the cat. Brain research bulletin. vol 11. issue 6. 1984-03-08. PMID:6318917. |
gaba in the intralaminar thalamic nuclei modulates dopamine release from the two dopaminergic nigro-striatal pathways in the cat. |
1984-03-08 |
2023-08-12 |
cat |
| A L Jadhav, R N Willett, H N Sapru, M F Lokhandwal. Involvement of central dopamine receptors in the hypotensive action of pergolide. Naunyn-Schmiedeberg's archives of pharmacology. vol 324. issue 4. 1984-03-08. PMID:6664381. |
the involvement of central dopamine receptors in the hypotensive action of the dopaminergic ergoline, pergolide was determined in anesthetized rats. |
1984-03-08 |
2023-08-12 |
rat |
| C G Clough, K J Bergmann, M D Yah. Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration. Advances in neurology. vol 40. 1984-03-07. PMID:6695589. |
these findings are interpreted as indicating that the dopaminergic receptors are available for stimulation during the off phase but are not receiving sufficient neurotransmitter, that is, dopamine, to stimulate their activity. |
1984-03-07 |
2023-08-12 |
Not clear |
| J M Lee, J Z Fields, R F Ritzman. Cyclo(Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine: agonist binding to D2 dopamine receptors correlates with stereotypic behavior. Life sciences. vol 33 Suppl 1. 1984-03-02. PMID:6229678. |
cyclo(leu-gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine: agonist binding to d2 dopamine receptors correlates with stereotypic behavior. |
1984-03-02 |
2023-08-12 |
Not clear |
| K Chihara, J Iwasaki, N Minamitani, H Kaji, H Kodama, T Fujita, K Shirataki, N Tamaki, S Matsumot. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers. Acta endocrinologica. vol 105. issue 1. 1984-03-02. PMID:6421041. |
to clarify the functional characteristics of prolactin (prl)-producing adenoma cells, the effect of trh, prostaglandin e1 (pge1), theophylline, dopamine and dopaminergic antagonists on prl secretion was examined in vitro in perifused pituitary adenoma tissues obtained at surgery from 8 patients with prolactinoma. |
1984-03-02 |
2023-08-12 |
human |
| K Chihara, J Iwasaki, N Minamitani, H Kaji, H Kodama, T Fujita, K Shirataki, N Tamaki, S Matsumot. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers. Acta endocrinologica. vol 105. issue 1. 1984-03-02. PMID:6421041. |
in one adenoma responsive to dopamine but resistant to sulpiride, ym-09151-2 (relatively specific d1-dopamine receptor blocker, 5 x 10(-7) m) antagonized the dopaminergic inhibition of prl release. |
1984-03-02 |
2023-08-12 |
human |
| G D Ellison, M S Eiso. Continuous amphetamine intoxication: an animal model of the acute psychotic episode. Psychological medicine. vol 13. issue 4. 1984-02-28. PMID:6320247. |
at about the same time there are distinctive and partially irreversible alterations in dopaminergic innervations of the caudate nucleus, but not in mesolimbic dopamine innervation of the nucleus accumbens or in several other neurotransmitter systems. |
1984-02-28 |
2023-08-12 |
rat |
| B Ehinge. Connexions between retinal neurons with identified neurotransmitters. Vision research. vol 23. issue 11. 1984-02-24. PMID:6140790. |
the dopamine turnover in the dopaminergic interamacrine cells is very rapidly activated by light. |
1984-02-24 |
2023-08-12 |
monkey |
| E Jungmann, M Wächtler, U Schwedes, K H Usadel, K Schöfflin. The effect of metoclopramide and haloperidol on plasma renin activity and aldosterone levels in rats. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie. vol 183. issue 2. 1984-02-24. PMID:6361937. |
our study confirms both dopaminergic inhibition of pra and stimulation of aldosterone secretion by dopamine antagonists in rats. |
1984-02-24 |
2023-08-12 |
rat |
| S E Kjeldsen, I Eide, I Aakesson, R Amundsen, I L Eriksen, P Lere. Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension. Acta medica Scandinavica. vol 214. issue 5. 1984-02-20. PMID:6660046. |
however, increased plasma free dopamine may be involved in the hypotensive effect of chronic beta-adrenergic blockade, both beta-1 selective and non-selective, and may lend further support to decreased dopaminergic activity in essential hypertension. |
1984-02-20 |
2023-08-12 |
Not clear |
| F Daudet, V Leviel, C Kerny, B Guibert, C Barberi. Effects of naloxone on dopamine release in the nigrostriatal system. European journal of pharmacology. vol 95. issue 3-4. 1984-02-15. PMID:6317411. |
it is concluded that antagonism between nal and amph could be due: (1) to enkephalinergic control of dopamine regulated nigral efferents, (2) to an action on the thalamic structures responsible for the reciprocal control of the two nigrostriatal dopaminergic pathways. |
1984-02-15 |
2023-08-12 |
Not clear |
| A J Friedhof. A strategy for developing novel drugs for the treatment of schizophrenia. Schizophrenia bulletin. vol 9. issue 4. 1984-02-14. PMID:6140754. |
antipsychotic drugs currently in use have been developed as antidopaminergic agents; that is, normalization of psychotic symptoms occurs through a reduction in dopaminergic activity, usually by blockade of postsynaptic dopamine receptors. |
1984-02-14 |
2023-08-12 |
Not clear |
| G Aguilera, K J Cat. Dopaminergic modulation of aldosterone secretion in the rat. Endocrinology. vol 114. issue 1. 1984-02-14. PMID:6317344. |
these actions of mcp were completely abolished by the simultaneous infusion of dopamine (2 micrograms/min), suggesting that the effects of mcp on adrenal function are due to its dopaminergic antagonist properties. |
1984-02-14 |
2023-08-12 |
rat |
| N Tod. Heterogeneity in the response to dopamine of monkey cerebral and peripheral arteries. The American journal of physiology. vol 245. issue 6. 1984-02-14. PMID:6660314. |
it is concluded that dopamine preferentially relaxes monkey cerebral and mesenteric arteries, possibly via dopaminergic receptors. |
1984-02-14 |
2023-08-12 |
monkey |